This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006. The findings from this book provide a long-term perspective to policymakers. This book discusses from the following points: industrial standardization, healthcare market accessibility, motivation on supply side, WHO medicines policy and intellectual property rights. Standardization regulates the quality and enabled the generic medicines spreading to developing/emerging countries through technology transfer. However, quality is a part of cost and reflected to price. When a healthcare service market is divided according to wealth gap, compliance to standardization for quality on supply side is divided accordingly. Thus, poor quality pharmaceuticals are prevalent worldwide. Generic pharmaceuticals are essential resources in public health. The WHO has been involved in the dispute around the intellectual property rights under its intention to promote the new drug development for neglected diseases. Global pandemic of AIDs is a critical factor to accelerate the confusion. This created feelings of distrust among developing/emerging countries against developed countries if the WHO was in favour of developed countries. In addition to that, an easy and optimistic start of IMPACT stirred up conflicts of interests in the international community. The problem of poor quality pharmaceuticals became more complicated through the conflicts on intellectual property rights; patented drugs to generic drugs. A key for quality generic products is the formation of a single healthcare service market where good motivation on supply side together with fair competitiveness with patented pharmaceuticals and equitable access to services (both for the rich and the poor) are ensured. Political commitment to investment and regulatory infrastructure for the market is crucial.
This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006. The findings from this book provide a long-term perspective to policymakers. This book discusses from the following points: industrial standardization, healthcare market accessibility, motivation on supply side, WHO medicines policy and intellectual property rights. Standardization regulates the quality and enabled the generic medicines spreading to developing/emerging countries through technology transfer. However, quality is a part of cost and reflected to price. When a healthcare service market is divided according to wealth gap, compliance to standardization for quality on supply side is divided accordingly. Thus, poor quality pharmaceuticals are prevalent worldwide. Generic pharmaceuticals are essential resources in public health. The WHO has been involved in the dispute around the intellectual property rights under its intention to promote the new drug development for neglected diseases. Global pandemic of AIDs is a critical factor to accelerate the confusion. This created feelings of distrust among developing/emerging countries against developed countries if the WHO was in favour of developed countries. In addition to that, an easy and optimistic start of IMPACT stirred up conflicts of interests in the international community. The problem of poor quality pharmaceuticals became more complicated through the conflicts on intellectual property rights; patented drugs to generic drugs. A key for quality generic products is the formation of a single healthcare service market where good motivation on supply side together with fair competitiveness with patented pharmaceuticals and equitable access to services (both for the rich and the poor) are ensured. Political commitment to investment and regulatory infrastructure for the market is crucial.
This thesis presents first observations of superconductivity in one- or two-atomic-scale thin layer materials. The thesis begins with a historical overview of superconductivity and the electronic structure of two-dimensional materials, and mentions that these key ingredients lead to the possibility of the two-dimensional superconductor with high phase-transition temperature and critical magnetic field. Thereafter, the thesis moves its focus onto the implemented experiments, in which mainly two different materials thallium-deposited silicon surfaces and metal-intercalated bilayer graphenes, are used. The study of the first material is the first experimental demonstration of both a gigantic Rashba effect and superconductivity in the materials supposed to be superconductors without spatial inversion symmetry. The study of the latter material is relevant to superconductivity in a bilayer graphene, which was a big experimental challenge for a decade, and has been first achieved by the author. The description of the generic and innovative measurement technique, highly effective in probing electric resistivity of ultra-thin materials unstable in an ambient environment, makes this thesis a valuable source for researchers not only in surface physics but also in nano-materials science and other condensed-matter physics.
In Detective Fiction and the Rise of the Japanese Novel, Satoru Saito sheds light on the deep structural and conceptual similarities between detective fiction and the novel in prewar Japan. Arguing that the interactions between the two genres were not marginal occurrences but instead critical moments of literary engagement, Saito demonstrates how detective fiction provided Japanese authors with the necessary frameworks through which to examine and critique the nature and implications of Japan’s literary formations and its modernizing society. Through a series of close readings of literary texts by canonical writers of Japanese literature and detective fiction, including Tsubouchi Shoyo, Natsume Soseki, Shimazaki Toson, Sato Haruo, Kuroiwa Ruiko, and Edogawa Ranpo, Saito explores how the detective story functioned to mediate the tenuous relationships between literature and society as well as between subject and authority that made literary texts significant as political acts. By foregrounding the often implicit and contradictory strategies of literary texts—choice of narrative forms, symbolic mappings, and intertextual evocations among others—this study examines in detail the intricate interactions between detective fiction and the novel that shaped the development of modern Japanese literature.
In the capital of the political power of feudal Japan, Kyoto, around 1540, a clan of formidable swordsmen who had previously dedicated themselves to trade and the production of colors for dyeing fabrics began to emerge. However, their exploits as master swordsmen lasted only four generations; they then died out or had to return to their previous economic activities. More than for their skills as instructors of the house of the shogun, they, in fact, went down in history for a number of battles lost against Shinmen Munisai, and his legendary son, Miyamoto Musashi. In the stories passed down to us, truth and myth are blurred, leaving the researcher and the reader with many unanswered questions and doubts. Who were the Yoshioka? When did their exploits as swordsmen begin? Where did their martial art come from? Who were their opponents? Were they really defeated or killed in duels against Miyamoto Musashi?
Proceedings of the 7th Annual International Workshop on Bioinformatics and Systems Biology (IBSB 2007), Institute of Medical Science, University of Tokyo, Japan, 31 July-2 August 2007
Proceedings of the 7th Annual International Workshop on Bioinformatics and Systems Biology (IBSB 2007), Institute of Medical Science, University of Tokyo, Japan, 31 July-2 August 2007
This volume contains 31 peer-reviewed papers based on the presentations at the 7th International Annual Workshop on Bioinformatics and Systems Biology (IBSB 2007) held at the Human Genome Center, Institute of Medical Science, University of Tokyo from July 31 to August 2, 2007. This workshop started in 2001 as an event for doctoral students and young researchers to present and discuss their research results and approaches in bioinformatics and systems biology.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.